AHCYL1 Is a Novel Biomarker for Predicting Prognosis and Immunotherapy Response in Colorectal Cancer

BACKGROUND: Colorectal cancer (CRC) is the third most frequent cancer worldwide. The AHCYL1 gene is required for CNV and has a close association with the tumor immune microenvironment. However, the predictive value of the AHCYL1 gene in patients with CRC remains unknown. METHODS: AHCYL1 gene with pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xubin, Zhang, Mengqiao, Yu, Xue, Xue, Mei, Li, Xiaowei, Ma, Chao, Jia, Wei, Gao, Qiang, Kang, Chunbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107370/
https://www.ncbi.nlm.nih.gov/pubmed/35578598
http://dx.doi.org/10.1155/2022/5054324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107370/
https://www.ncbi.nlm.nih.gov/pubmed/35578598
http://dx.doi.org/10.1155/2022/5054324

Ejemplares similares